About: http://webisa.webdatacommons.org/448421958

Property	Value
http://www.w3.org/1999/02/22-rdf-syntax-ns#type	http://www.w3.org/ns/prov#Entity
http://www.w3.org/ns/prov#value	COVA322 is Covagen's lead bispecific FynomAb?? developed for treatment of patients with rheumatoid arthritis, psoriatic arthritis and other inflammatory diseases.
http://www.w3.org/ns/prov#wasQuotedFrom	biospace.com